Confidentiality Marketing Public Use 
Garrigues Blog
NOVEMBER 15, 2021
This opposition procedure for European patents is particularly useful when the patent in question is hindering our commercial interests and we have adequate reasons to revoke its registration. One of the most effective ways of obtaining the revocation is to prove “prior public use”. We look at what this consists of below.
Patently-O
AUGUST 5, 2024
The basic holding is that the 102(a)(2)/(b)(2) safe harbor triggered by an inventor’s pre-filing “public disclosure” of the invention requires that the invention be made “reasonably available to the public.” ” Neither public uses nor private sales satisfy this requirement. 333 (1881).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Larson & Larson
FEBRUARY 13, 2021
It’s the legal term for ‘thing that is exactly like my thing that was in the public before I made my thing.’ The term covers anything that was sold in public, used publicly, described in a magazine or similar publication, or already has a patent on file with the patent office. Exceptions.
Kluwer Copyright Blog
MARCH 8, 2023
Having called the parties to submit their memorandums and present their opinions and arguments against each other, the Committee is entitled, even if one of the parties did not take part in the procedure, to issue a confidential opinion regarding the appropriate amount of the remuneration due, on the basis of the criteria set out in the Regulation.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. Yet biosimilars of anti-TNF?
Expert insights. Personalized for you.
98 
Let's personalize your content